Replies to post #28353 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[nep2134]

With Vertex Pharmaceuticals cystic fibrosis announcement Corbus could be a good short. Unless they can show a lung function improvement, why bother doing a phase 3.

Jenkins strikes out again.